Sentient Brands Holdings Inc.

Sentient Brands Holdings Inc., a product development and brand management company, focuses on building innovative brands in the luxury and premium market space. It intends to offer CBD luxury skin care and lifestyle products, such as purifying exfoliator, replenishing facial oil, ultra-nourishing face cream, revitalizing eye cream, high potency THC, fragrance amulets, CBD infused candles, and CBD infused women's fragrance under the Ouevre brand through direct-to consumer online e-commerce platform, as well as wholesale partners. The company was formerly known as Intelligent Buying, Inc. and changed its name to Sentient Brands Holdings Inc. in March 2021. Sentient Brands Holdings Inc. was founded in 2002 and is based in New York, New York.

Sentient Brands Holdings Inc. trades as SNBH on OTC. The company is classified in Consumer Defensive / Household & Personal Products and reports in USD.

The current profile places the business in Household & Personal Products. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $701,463 of revenue and -$1.20M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Sentient Brands Holdings Inc. can be compared against peers such as AiXin Life International, Inc., CleanGo Innovations Inc., Full Motion Beverage, Inc., Glucose Health, Inc., Horrison Resources Inc., Psyched Wellness Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $181,948, beta of -0.35, and return on equity of +57.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SNBH currently shows total debt of $880,137 and beta of -0.35. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 3 (2026-05-22 00:00:00), 3 (2026-05-22 00:00:00), 10-Q (2026-05-14 00:00:00), 8-K (2026-05-04 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.sentientbrands.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.